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Abstract
Objective: To understand how medical mistrust impacts perceptions of PrEP and willingness
to use PrEP for African American and Hispanic men and women in New Haven, Connecticut.
Methods: This qualitative study utilized semi-structured interviews to examine medical
mistrust, PrEP awareness, and willingness to use PrEP amongst African American and Hispanic men
and women in New Haven, Connecticut.
Results: The majority of participants did not know about PrEP before their first interview of
this study and the majority of participants did not decide to use PrEP over the course of this study.
For those who are not interested in using PrEP, 3 common concerns accompanied their unwillingness
to use PrEP, including: 1) concerns about PrEP as a medication, 2) need for improved provider care
and knowledge; and 3) perceptions of patient prioritization based on past experiences. For those who
did choose to use PrEP or who had partners who chose to use PrEP during the course of the study,
perceived risk of HIV and a source of education about the benefit of PrEP outside of the medical
establishment were common denominators. Discussions of perceptions of PrEP and participant
willingness to use PrEP revealed how medical mistrust impacts perceptions of PrEP and willingness
to engage with what is seen as an unnecessary preventative medication.
Implications: Medical mistrust impacts perceptions of PrEP and willingness to engage in
HIV preventative measures such as PrEP. As a result, medical mistrust is a significant barrier to
willingness to engage in HIV prevention measures using PrEP because it is not trusted. For those that
do choose to utilize PrEP or have a partner that does, it is clear that sources of information alternative
to traditional healthcare venues can educate about PrEP in a relatable and trustworthy way.
Additionally, it is clear that provider education about PrEP is necessary for those patients that do
choose to interact with medical systems to obtain PrEP, despite their mistrust.
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Introduction
An extensive body of literature has established that medical mistrust inhibits willingness
to engage with the medical system, as well as to follow provider recommendations. Medical
mistrust has been defined as a distrust of medical practitioners and organizations (Omodei &
McLennan, 2000; Williamson & Bigman, 2018), and includes the tendency to not completely
trust medical systems and health care providers perceived to represent the dominant culture
(Bynum et al., 2012; Thompson, Valdimarsdottir, Winkel, Jandorf, & Redd, 2004; Boyas et al.,
2018). Additionally, medical mistrust has been categorized as distrust of the medical system that
results in a leeriness of the work and intentions of practitioners, identified to be self-preserving
and derived from “a long history of race-based differential treatment, unequal dissemination of
effective medical innovations, and other racist injustices within the medical establishment”
(Tekeste et al., 2019). Medical mistrust has been linked to a multiple attitudes and actions of
doctors, including perceptions that doctors are motivated by money, perception that doctors are
unreceptive to patients’ self-diagnoses or patients’ expertise about their own bodies, and by
perceptions that doctors are actually the root cause of events that have been extremely harmful to
communities do color such as the opioid epidemic (Underhill, 2015).
Medical mistrust is particularly important to understand in the context of pre-exposure
prophylaxis (PrEP) and HIV prevention, as it is often a barrier to interactions with the medical
system for those who have experienced medical or institutional racism or homophobia, or who
are simply aware of the generational mistreatment and discrimination that African American and
Hispanic, as well as LGBTQ people have faced in the United States medical system to date
(Cahill et al., 2017; Kalichman et al., 2016). Understanding and rectifying the institutional
shortcomings that breed medical mistrust is particularly important as the largest number of new
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cases of HIV annually occur among African American and Hispanic men who have sex with
men (MSM) (CDC, 2020). It has also been well established by previous studies that pre-exposure
prophylaxis (PrEP) is effective in preventing HIV when used as prescribed, yet it has not seen
the uptake amongst African American and Hispanic men at risk of contracting HIV that it has
seen for white men who have sex with men (MSM).
The United States medical system, primarily composed of white, male doctors has
perpetrated intergenerational harm against people of color (Lee et al., 2018; Quinn et al., 2019).
Doctors, healthcare systems, and the pharmaceutical companies make life or death decisions on a
daily basis for their patients. Current experiences of medical mistrust are grounded in a reality
the emerged from centuries of intentional decisions that impact who lives and who dies, who
faces disability and who doesn’t, and who receives treatment and who doesn’t. When
communities of color and LGBTQ people watch the healthcare system actively work against
them, or even passively not work for them, it becomes extremely hard to discern who and what is
worth trusting. This study builds on prior literature by expanding to include perceptions of
diverse sexualities and genders within the same study. This research also expanded on current
literature to include the perceptions of formerly incarcerated men and women whose unique
experiences while incarcerated impact their views of institutions, including the medical system.
It is important to identify and understand what factors contribute to medical mistrust, and how
medical mistrust impacts willingness to engage in preventive medicine so that healthcare systems
and providers can work to reach the patients most at risk for HIV.
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Methods
Study Design and Sample
This research was conducted as part of the Justice, Housing, and Health Study
(JustHouHS) study, a five-year longitudinal study funded by the National Institute of Mental
Health, which focuses on examining mass incarceration, housing stability, and subsidized
housing policies, which are three interrelated social determinants of HIV/ STIs, to determine
how they interact to shape sexual health risk. One aim of this study is to understand, from the
perspective of vulnerable populations, how mass incarceration, housing stability, and experience
with subsidized housing policies intersect to impact HIV/ STI related sexual risks, and how these
factors interact to produce racial disparities in these risks. This was all based on self-report.
Recent release from prison was defined as one year from date of screening, based on selfreported approximate last release date and controlling charge. This information was confirmed to
be approximately correct using publicly available sentencing data available on CT’s judicial
branch website. Qualitative interviews were conducted every six months with a subset of
JustHouHS survey participants.
Recruitment Methods
Participants for this research were recruited from New Haven, Connecticut. All those
eligible for this study were identified as either low income or as having recently been released
from prison. Low income was defined as: being homeless; residing in a low-income census tract
area (defined as more than 20% of residents living below the federal poverty level), receiving
housing assistance, receiving SNAP benefits within the past year, or being on Medicaid.
Participants were recruited using convenience sampling, but to avoid under or over sampling
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certain groups, regular data review and assessments were conducted to match study participant
demographics as accurately to New Haven area low income and formerly incarcerated residents
as closely as possible (N=400). A subset of the quantitative population was chosen from the total
quantitative population randomly based on those who indicated their interest in participating in
the baseline quantitative survey. A total of 54 participants were selected, with 27 being part of
the low-income group, and 27 being part of the group of participants having experienced some
type of criminal justice involvement in the past year. Enrollment took place between December
2017 and June 2018.
In order to examine the relationship between medical mistrust and perceptions of PrEP
for communities of color, all participants who identified as white were excluded for the purposes
of this paper, as were all participants that did not mention PrEP or pharmaceutical based HIV
prevention in a single one of what could be up to four interviews conducted with each
participant. As a result, this study includes only 33 of the original 54 participants. Of the 33
participants included for purposes of this study, 24 (72.7%) identified as African-American, 9
(31%) identified as Mixed or Other race. The majority of those self-identified as Hispanic. 7
(21.2%) identified as female, and 26 (78.8%) of identified as male. The average baseline age of
participants was 43 years old, with a range of 24 to 64 years old. 17 (51.5%) had been
incarcerated in the past year at baseline, and 16 (48.5%) self-identified as low-income. 4 (12.1%)
were HIV positive, and 29 (87.9%) were not HIV positive.
Data Collection
Interviews were conducted in a central office to the urban area, accessible by public
transportation. This building was not directly associated with Yale University, or Yale’s campus,
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but it was located adjacent to the campus. Semi-structured qualitative interviews were conducted
every 6 months with 54 participants enrolled in the qualitative arm. A baseline, follow up 1
(conducted ~6 months following BL), a follow up 2 (conducted ~6 months following FU1), and
a follow up 3 (conducted ~6 months following FU2) interviews were all conducted with
participants over the course of two years for a total of up to five interviews each. The majority of
interviews were completed in-person, although occasionally an interview was conducted over the
phone if it was not possible for a participant to visit the office (e.g. in the case of an out of town
move). All participants received a $50 gift for each interview that they participated in. There
interviewers conducted all interviews, and the same interviewer interviewed each participant for
all of the interviews conducted with that participant.
Data Analysis
Data were coded using NVivo 12. Data analysis began by indexing interviews for major
topics of interest for the project with the 54 enrolled in the interviews. I conducted open coding
on the data already coded under “HIV”, which was a child node to the parent node, “Health.”
The child node “HIV” included all references to HIV, HIV prevention, or opinions and thoughts
around the subject including experiences, perceptions or opinions of PrEP. From the HIV data, a
search was conducted for the word “PrEP” to determine which participants discussed PrEP in
their interviews. We also created longitudinal analytic memos for relevant participants on the
subjects of medical mistrust, perceptions of HIV testing and PrEP, as well as HIV stigma.
Longitudinal memos served as short analytic reports created about relevant participants to further
explore themes surrounding PrEP and medical mistrust over the course of all interviews
conducted with each participant. Qualitative matrices, which were created to provide information
on a variety of relevant topics were used to determine relevant background information to
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participant’s experiences and perceptions surrounding their health, particularly their sexual
health. An additional matrix was created to include relevant participant mentions of PrEP.
Results
Question: What are the social, structural, and institutional factors that shape medical mistrust in
New Haven, Connecticut, and how does this impact willingness to use PrEP?
Three common themes emerged around medical mistrust and willingness to use PrEP in
these interviews:
1. Concerns about PrEP as a medication;
2. Need for improved provider care and knowledge;
3. Perceived exploitation by a for-profit healthcare system

The results reflect the perceptions of African American and Hispanic residents of New
Haven. Three main themes emerged when participants were asked about willingness to take
PrEP as well as perceptions around PrEP. The majority of participants had not heard of PrEP
prior to their baseline JustHouHS interview. Additionally, the majority of participants were not
open to taking PrEP. The most common theme related to medical mistrust that contributed to
participant unwillingness to take PrEP were concerns about PrEP as a medication, and general
concerns surrounding PrEP as a fairly new medication meant to prevent a stigmatized disease.
Additionally, another theme emerged through concerns around PrEP and HIV, indicating a need
for improved provider care and knowledge as many participants discussed never having heard of
PrEP, despite regular provider visits. Finally, many participants' perceptions of patient
exploitation by a for-profit healthcare system contributed to willingness to use PrEP as a
preventative measure against HIV. The majority of participants, whether or not they expressed
9

interest or willingness in potentially taking PrEP daily for HIV prevention did not begin to do so
during the course of this study. Only three participants took PrEP over the course of this study,
and their experiences were unique from those who did not take PrEP.
Concerns about PrEP as a medication
The majority of participants who were asked about PrEP had not heard of it prior to their
first JustHouHS interview. However, both for those who had heard of PrEP as well as those who
had heard of PrEP prior to their first interview, concerns surrounding PrEP as a medication
abounded. Pharmaceutical preventative measures against HIV were seen as unnecessary at best
and potentially extremely harmful, even hypothetically increasing HIV risk, at worst. When one
participant, Jackson, is asked about PrEP in his second follow up interview, his first response is
to question the side effects, particularly in relation to the relative newness of PrEP.
Shit. Do you think they even know? Probably not, right, 'cause it's kind of new?
[Jackson, male, 24]
The idea that even pharmaceutical companies or prescribers might not be aware of the full extent
of potential side effects, especially in the early stages of prescribing was concerning to many
participants, regardless of whether or not they had some prior knowledge of PrEP. Participants
expressed a great deal of institution-based medical mistrust for pharmaceutical companies as
well as the products that they create. In a follow up interview, Jackson brought up PrEP himself,
without a prompting question. When he talked about PrEP in this follow up interview his
perceptions imply that his distrust for the medication extended to distrust for those who create it.
Have you heard about that medication, the Truvada thing?...I heard people are getting
HIV from it. Crazy. [Jackson, male, 24]
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When Jackson conflated PrEP with other disease preventative methods, such as vaccines which
may actually contain live viruses, his medical mistrust only increased. Participants value control
over what goes into their body, and without explicit understanding of the potential impact of
taking a pill, particularly a preventative, it is seen as unnecessary or even potentially harmful.
Cole is one participant who anticipated extremely negative likely side effects from taking
PrEP when he learned about it. Cole was incarcerated in the past year prior to his first interview,
and in his first interview he discussed being sexually active with multiple female partners he
knew were sexually active with other men. When Cole was first asked if he was interested in
taking PrEP in his first follow up interview, he turned the question back on his interviewer. He
asked the interviewer if she has taken PrEP as a gauge for whether or not he should. When the
interviewer replied that she hasn’t ever taken PrEP, he acted almost resentful that she would ask
him to try it.
Then don't try to get me to take that shit...It's all the side effects, my ears would be
bleeding, eyes fall out, rolling down the street...What the fuck, dude? Is that gonna stop
me from getting chlamydia or herpes? [Cole, male, 33]
Like other participants, Cole was very leery of potential side effects of a medication that is
relatively new, and that he deemed unnecessary for himself. For Cole, the potential benefits of
PrEP are outweighed completely by the potential risks to his body. He expressed not wanting to
be negatively impacted by what he perceived could be a failed pharmaceutical experiment of a
potentially malicious medicine.
Avery is one of the few participants who had heard of PrEP prior to his involvement in
the JustHouHS Study. Despite having some prior knowledge of the medication, he was still
extremely leery of how it could impact him and his body.
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Oh yeah, I seen it, but I wouldn’t be interested in doing that. Because why would I be
interested in something that’s to prevent HIV – like I feel that’s probably gonna get me
HIV. Who knows? I don’t know how they ever experimented and tested with that. It’s like
a male birth control to HIV? No, I’m not trying. What if that does something to my body
eventually – I think it’s like taking an ibuprofen when you ain’t even got a headache.
[Avery, male, 25]
Additionally, Avery viewed the preventative nature of PrEP as entirely unnecessary for him, and
possibly even harmful. A drug that is purely for prevention is viewed as something that could
cause bodily harm, particularly when participants doubt that there is a significant knowledge
base surrounding the drug. Avery equated PrEP to a risky “male birth control” that could fail and
result in HIV contraction.
Unknown and untested side effects made many participants extremely leery of taking a
preventative medication for HIV, particularly if they did not view themselves as at high risk for
HV. When Chase is asked if he would be willing to take PrEP for HIV prevention, and focused
on potentially detrimental side-effects.
Uh, I’m real sketchy depending on the side effects, because nowadays everything that you
take…it's worse than the actual, like, what it's supposed to help you with. Like you'll see
[referencing tv pharmaceutical ads talking about side effects]—and then they try to say it
all fast but nobody really pays attention. Like, they got, like, um…uh, medication for, like,
asthma, and they're like, ‘side effects may, um, occur in bloody stools, and this, that and
the third.’ It's like, wait, what? So, any time I fart I'm gonna be bleeding and I may want
to kill my wife but I won't cough as much. That's crazy... It's FDA-approved too, like
that's insane. [Chase, male, 35]
Like Chase, many participants believed that taking PrEP may be more detrimental than
beneficial to them based on what they perceived to be potentially life altering side effects that
those who prescribe the medications as well as pharmaceutical companies are far from
transparent about. These participants perceived their potential HIV risk as less than the potential
risk of taking a preventative medication.
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Need for improved provider care and knowledge
For participants already mistrustful of systems and institutions, primary care providers
that cause confusion and unnecessary concern only exacerbate participant medical mistrust.
Multiple participants indicated a strong need for improved provider care and knowledge in order
for PrEP utilization rates to increase. Providers that use fearmongering tactics to educate about
HIV prevention, providers that are not knowledgeable about PrEP, and providers that do not
offer PrEP to patients that would benefit from it all contribute to low PrEP uptake levels.
Overexaggerating how easy it is to get HIV can be extremely detrimental to participants.
This is particularly true because a belief in the efficacy of preventative healthcare methods is
vital to believing that PrEP has the capacity to effectively prevent HIV. If patients do not believe
that HIV is something that can be prevented by PrEP, they will be extremely unlikely to ever
take PrEP for HIV prevention. Even when participants received (arguably) accurate medical
information that they trust, participants reported having providers that used fear mongering. This
generated a feeling of skepticism that served as a barrier to medical system trust, obstructing
participants’ willingness to trust medical knowledge in general. One participant, Elijah, believed
that he had an adequate understanding of HIV transmission prior to receiving more minute detail
from one provider.
When I came home [from prison], when I took– when I first took my [HIV] test, the lady
told me, she said, ‘There's so many ways that you can catch it now.’ That it's now – it's
not just, you know, the intercourse. It's just, if you get a cut. Today, it could be anything.
And I’m like, ‘So, what, did it change?’ Because before, I thought it was just, um, if you
had sex, unprotected sex or if you had a cut and if somebody else had a cut and...Now
they saying it's saliva. They say you can get…. if you got chapped lips and you're
smoking with somebody, you're smoking a cigarette. [Elijah, male, 41]
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While the information that Elijah was given is technically factual, it is extremely odd that a
responsible provider would emphasize what his provider did, as the level of transmission she
described occurs extremely rarely (if at all). This fear mongering made this participant doubt his
prior knowledge of HIV and instilled a new fixation on novel possibilities that could result in
him contracting the virus. Following this encounter with a primary care provider, Elijah felt that,
when it comes to HIV, it is nearly impossible to engage in seemingly benign behaviors without a
small risk that something extraordinary could happen. When HIV is portrayed as something
sinister, it is difficult for participants, like Elijah, to imagine that a preventative drug such as
PrEP has the capacity to prevent HIV with any reasonable level of certainty.
In addition to encountering fear tactics in their interactions with providers, some
participants noted that providers seemed to be uneducated about PrEP, what it does, and how it
works, which also impeded participants’ willingness and ability to engage in PrEP. Bently is one
participant who prioritized his own HIV prevention and was on PrEP at his first interview. He
hasn’t experienced any side effects and felt that PrEP was working well for him. However, as
someone who was unstably housed and did not have a consistent primary care provider, he found
himself using PrEP on and off while he worked to get this prescription refilled. Having to renew
PrEP prescriptions with a variety of different providers forced Bently to experience how multiple
different providers interact around PrEP. Unfortunately, he described often having to educate
providers on what PrEP is and why he wanted to be prescribed it.
A lot of people don't even know what PrEP is, like, I swear to God, at least half the
doctors that I've seen, they are, like, ‘you're out of PrEP—what? I don't know what that
is’...And then I gotta explain it for 20 minutes and it's annoying. Seriously...Yeah, you'd
think they would. They don't. They have no idea. [Bently, male, 27]
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When primary care providers were not knowledgeable about PrEP and patients such as Bently
needed to educate their own physicians, it did not inspire confidence that these doctors
understood the medication or knew how it might impact their patients. When patients had to
educate their providers, they lost the belief that their providers are knowledgeable and worthy of
their trust. This is particularly harmful for patients who would be ideal candidates for PrEP, but
had providers entirely unaware of PrEP. Provider ignorance should not impede PrEP uptake for
those who would most benefit from it, particularly for those who have identified the benefits of
PrEP for themselves on their own.
Another dimension of patient/provider relationships that impacted PrEP uptake and
medical mistrust was the failure of health care providers in institutionalized settings to offer
PrEP to their patients. For formerly incarcerated participants in particular, providers in prison are
seen as equally a part of medical institutions as health care professionals outside of prison. For
formerly incarcerated participants, a failing on the part of prison primary care providers is a
failing representative of the healthcare system in general. Multiple participants who had been
formerly incarcerated expressed that PrEP is not something offered in prisons, despite prison
populations being particularly at risk for contracting HIV. Carlos is one participant who could
not understand why the health care providers in prison did not educate prisoners about PrEP and
work to increase HIV prevention methods available in prison.
The first time I ever heard of it is from you guys. They don't even talk – that's something
they should talk about in jail. They should let people know about that...'Cause there's a
lot of people in jail with AIDS – HIV, AIDS, one or the other. [Carlos, male, 30]
Carlos also could not understand why information about a medication to prevent HIV would not
be readily available to all who could benefit from it. This made him question the integrity of
health care providers that serve prisoners, which contributed to his general institutional mistrust.
15

Isaiah is another participant who believed providers should offer PrEP to their patients,
particularly to patients in the homeless community.
I think that they could advertise it more in a homeless community, you understand,
because I had to go to them in reference to PrEP. They didn't come to me...like I said, I
shouldn't have had to go to them in reference to that. And they knew that I was a gay
man, so… They could have asked me…You know, so stuff like that makes you think.
[Isaiah, male, 46]
Isaiah lamented the lack of advertisement for PrEP in the homeless community, because he
believes many in the community he once belonged to could benefit from PrEP. Additionally, he
feels resentful and mistrustful that as an openly gay man, no provider of his ever offered him
PrEP.
When participants begin to feel that community providers have caused and continue to
cause more harm than healing, it can be difficult to trust medications and the providers involved
in distributing them, particularly in a community with a sub-culture surrounding pharmaceuticals
sold outside the confines of traditional pathways to obtaining medications. Jackson is one
participant who has heard of the existence of counterfeit PrEP in the same context as other
counterfeit goods and drugs that are sold outside the confines of medical institutions.
It could be a counterfeit PrEP that's giving people stuff [like HIV], 'cause there's a lot of
counterfeit medications. Think about it. How the hell do you have Fentanyl in
drugs?...Everybody's talking about it online. Plus, even doctors are talking about it...It's
like Fentanyl. How the hell did Fentanyl get into heroin and, like, weed and stuff? Where
do you get Fentanyl from? You get it from a pharmacy or you get it from a hospital. How
is Fentanyl coming onto the streets like in large bulks like that? There's only a couple
ways. The nurse want—the nurses want to make money. It could be nurses simply stealing
it from the thing. There's nurses that do that all the time. Or the nurse could be fucking
with somebody on the streets or whatever and doing it for, you know, money, staying, sex
with him. There's a lot of different ways stuff, you know, goes apart. But I feel like
sometimes the truth is just—it's in front of our face. [Jackson, male, 24]
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Medications used for prevention are often seen as particularly worthy of mistrust, as medical
providers often intentionally emphasize that prevention methods such as PrEP are not infallible.
Consequently, prevention methods can be conflated with an increased susceptibility to a disease
or virus. Jackson’s medical mistrust has left him vulnerable to information that, while medically
inaccurate, seemed plausible based on what he has heard about PrEP and other pharmaceuticals.
In a system built to prioritize profit over patient care, it can be difficult to trust provider
intentions or even medication legitimacy. Conspiracy and rumors about one medication or drug
can easily be conflated with those of others, creating ideas that corporate medical institutions and
those that work in them do not have the best of intentions, and that they do not prioritize their
patients.

Perceived exploitation by a for-profit healthcare system
Participants leery of taking PrEP often discussed instances of perceived patient
exploitation occurring at the hands of a health care system believed to prioritize profits over
patient health and well-being. When participants believed that healthcare institutions did not
have their best interests in mind, medical mistrust and unwillingness to engage in preventive
medicine was exacerbated. A research institution dominates the small urban area in which this
study took place, and has a complicated relationship with the small urban area and its community
members. As in many small cities home to large research institutions, the cities’ most
disadvantaged have been enlisted in countless research studies. As a result, trusting the same
institutions that have perpetrated harm to also provide healing in the form of medical care can be
difficult. Research studies, and their potential harm are well known here. The majority of lowincome people, particularly amongst communities of color, in this small city have either
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participated in research studies, or know someone who has. These studies included
pharmaceutical trials of drugs with unknown side effects that could have had unknown life-long
effects. Some participants referenced these experiences with pharmaceutical drug trials when
asked about PrEP. Cole is one of multiple participants that equated PrEP research studies with
harmful side effects for low income and vulnerable people.
There's the people right here down at, um, on the Green, the lab, the people that they test
out here. Right there...Yeah, that's what they did for PrEP...[Laughs] Yeah, it was done
at Pfizer for Yale and now they're out here on the Green looking crazy from the side
effects. [Laughter]...From them Yale studies. [Laughs] Nah. [Cole, male, 33]
To Cole it is clear that those around him have been exploited for the gain of the institution that
dominates his city, which makes trusting a preventative medication coming from a health
institution known to have its own agenda difficult. When an institution clearly holds its selfinterest paramount it makes genuine attempts to encourage patients to engage in pharmaceuticalbased preventative health care seem disingenuous.
Furthermore, for participants, it has seemed obvious in these for-profit institutions that
there might be more knowledge and medicine available for those that can pay for it, or those
privy to the intimate workings of medical institutions, which Cole perceived his Yale-affiliated
interviewer to be. When the interviewer inadvertently blinked before she asked Cole about his
opinions surrounding HIV, he questions whether she might have been granted access to
information ordinary community members would not be privy to.
Why'd you close your eyes when you said that?...Why, you know a secret or something?
[Laughs]...You close your eyes; what you heard about it [HIV]? [Laughter] What, you
got the cure, I’m sayin? [Laughs]...Do you work at Yale? [Laughs] You know somebody
that knows somebody. [Laughs] [Cole, male, 33]
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When the interviewer assured him that she has not received access to a cure, he continued to
push because he associates the institution that she works for as having access to health care,
including preventative medicine and cures unavailable to everyone. Many participants such as
Cole perceived a stark contrast between those “in the know” at a giant, powerful research
institution, and average community members. Participants such as Cole understand the nuances
of the relationship between the average members of his community and the powerful and
wealthy medical research institution that is part of the fabric that created modern medicine and
influenced modern research practices. Cole equated institutional power with knowledge he
perceives as inaccessible to him. Cole does not believe that institutions actively help those that
they treat to the full extent of their capabilities, because he believes that medical institutions have
the capacity to do more than they have done for the low-income communities of color in the
institution’s backyard.
For another participant, having family in the healthcare field has impacted his perceptions
of the medical system and its integrity. Johnny’s wife’s family member worked at a hospital and
witnessed a fellow employee breaking hospital rules at the expense of their patients.
[Wife’s] family member worked in a hospital. Out of jealousy, she went and told and
made some false accusations and I brought that to the doctor. She [the doctor] said, ‘You know
what? They just fired somebody for looking at somebody else's files when they shouldn’t’ve have
been.’...She was working at the same medical clinic that I attend now, but this was years ago.
But out of jealousy, you never know what people will say...But she said, ‘You know what,
Johnny? You raised a valid point. They just got rid of somebody for doing the exact same thing.
[Whispers] Like come here, look.’ So, one lady, her son died. Somebody took pictures of him at
the autopsy and posted them on Facebook...So now they're suing the hospital. [Johnny, 46, male]
Johnny no longer trusts institutions as a whole because he does not trust the individual people
that work within these systems. Participants question whether institutions are only as trustworthy
as their least trustworthy employee. Health is extremely valued and lost or damaged health may
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be irreversible. When government institutions have the power to positively impact health but
choose not to do so, they are causing harm.

Participants who chose to use PrEP
The experiences of participants who have chosen to use PrEP can provide insight into
ways that participants navigate varying levels and types of medical mistrust. All participants who
have chosen to go on PrEP at some point during the study were either men who have sex with
men (MSM) or people who have a long-term partner that is HIV positive. Other participants who
are HIV positive have had partners who use PrEP to protect themselves. The largest group of
people who use PrEP or have partners on PrEP do so because one partner in their dyad has been
diagnosed as HIV positive. Tyler is one participant who has been diagnosed as HIV positive and
wants to be absolutely sure that his partner is protected against HIV.
Yeah, listen, if I'm gonna have sex with you, I'm gonna tell you that I'm HIV positive. Now
it's on you, you know what I mean? I'll protect myself. We'll do everything possible to
protect ourselves to have sex. Okay, you're protected, but you gotta be careful, because
sometimes rubbers break. These things happen, all that. That's why it's good for your
partner to take the pill, just in case something like that happens. She's got backup, and
that's what I do with [current partner]. [Tyler, male, 50]
Tyler views PrEP as a preventative measure that is necessary for his partner because he is HIV
positive and does not want his partner to get HIV.
For two men who both identify as MSM, medical mistrust was satisfactorily addressed
enough to enable them to take PrEP because they received positive messages surrounding PrEP
from social sources outside the realm of medical institutions. One participant, Isaiah, recounted
originally seeing PrEP in the context of an MSM dating site which positively influenced his
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decision to go on PrEP, despite not always trusting his provider or the medical system to work
for the betterment and maintenance of his health.
I had actually heard about PrEP. I was on a dating site and I kept seeing – it kept saying
PrEP user... So, these individuals were actually saying or telling you…'I'm on
PrEP'…And that made me think about it. I said, ‘Well, let me ask my –’ 'cause they –
Cornell Scott [Community Health Center] never mentioned PrEP to me, [laughs] so I
said, ‘I'll mention it to them.’…And when I mentioned it to them, they said, ‘okay,’ and
they gave it to me, but the requirement is that every three months you get your HIV test. I
said, ‘I don't have a problem with that…That's even better.’ [Isaiah, male, 46]

Isaiah discussed the trust he gained in PrEP’s capability to prevent against HIV when he heard
about its efficacy from peers. When he heard about the benefits of PrEP from people actually
using it, Isaiah was inspired to request it from his primary care provider. Isaiah’s chose to use
PrEP is despite his medical mistrust. His baseline level of medical mistrust was accompanied by
an anger that he was forced to be his own advocate to his primary care provider, despite clear
indications that he might have been a good candidate for PrEP. Isaiah felt frustrated that he had
previously disclosed to his provider that he was sexually active with men, yet he had to tell his
provider that he wanted to be on PrEP. His provider had never mentioned PrEP to him. Isaiah
also recounted other experiences that made him mistrust his provider and turn him into his own
fiercest advocate. Isaiah realized that he must advocate for himself staunchly to his provider,
even when his healthcare provider does not want to listen to him.
Discussion
Participants highlight three main reasons for their medical mistrust surrounding PrEP,
which often negatively impacts their willingness to use the drug. Many participants emphasize
concerns about PrEP as a medication, the need for improved provider care and knowledge, and
perceived exploitation by a for-profit healthcare system as the main contributors to their medical
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mistrust, which impacts willingness to engage with PrEP. Medical mistrust surrounding
medications is justified by participants because it is common knowledge that different
medications can have extremely negative side effects. Participants may have experienced
extreme side effects firsthand, learned about them from others, or they may equate previously
unbeneficial medication treatment courses to PrEP. When a medication is new, it is seen as
particularly potentially harmful, as there is a long history of medications approved as safe having
extreme adverse effects shortly after many people begin to use them.
When it is clear that community members are suffering from research gone wrong, it
impacts the capacity to trust the same institutions to take the health and wellness of all
community members equally seriously. Trusting medical providers is difficult enough after
generations of research that was often harmful to patients involved. Knowledge that similar
research continues today, often by medical research institutions on the very same vulnerable
community members that they serve does not bolster community institutional trust. Questioning
whether or not a doctor really has their patients, particularly their black and brown patients’ or
sexual and gender minority patients’, best interests at the forefront of their decision making
results in patients questioning the medical advice that they receive, which results in them
seriously entertaining the possibility of negative consequences of the cures and preventative
services offered by these institutions.
Our analysis suggests that it is a mistake to attempt to promote safer sex in a way that
makes individuals doubt their own knowledge and understanding of how HIV is transmitted.
Instead, providers should educate their patients about HIV preventative measures such as PrEP.
Furthermore, patients should not have to serve as their own advocates in order to begin a PrEP
prescription for HIV prevention. Primary care providers, particularly those that work with
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populations particularly vulnerable to HIV, should have a strong understanding of PrEP and feel
comfortable prescribing it to any of their patients.
Additional research is needed to determine how institutional medical racism and
homophobia can be combated to ensure that those who would benefit from PrEP are not deterred
by medical mistrust that may have led to an unwillingness to continue to engage with a
healthcare system that they perceive to be more harmful than helpful. Since medical institutions
operate within a capitalistic, for-profit medical industrial complex, it is often difficult for lower
income or already stigmatized individuals to receive the healthcare or medication that they need
directly from the sources available to those with money or power. Institutions that deliver
healthcare as well as current infrastructure used to address and treat disease rely on their
reputations to engage with patients and offer advice that is seen as trustworthy. However, when
institutions run by the same government are seen not to work for people of color time and time
again, they lose their credibility. When people begin to feel that they live in a state in which
governmental institutions do not value human life, they begin to question whether all medicine
isn’t made to be malicious for those most vulnerable to disease.
Additionally, when institutions that are seen as responsible and make catastrophic
mistakes that negatively impact a specific group of people substantially more than others, this
can have a huge impact on how they are perceived. This impacts the ability of these
organizations to successfully serve as healthcare and health practice authorities. When
institutions fail to take precautions to protect their patients, they lose patient faith, regardless of
whether those failures are seen as negligent or malicious. However, when institutions are
maliciously irresponsible, they decrease patient trust further.
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Clinical Implications
Our data suggest that all physicians, particularly physicians involved in primary care in
any capacity should be thoroughly educated about PrEP as an effective form of HIV prevention.
No one should have their institutional mistrust amplified by ignorant providers. Additionally,
providers should be trained to understand that PrEP does not increase promiscuity. Providers
should be trained to describe and offer PrEP to all of their patients without stigmatizing it as a
preventative measure meant only for certain “at-risk” populations to increase PrEP uptake.
Additionally, peer education programs would be extremely beneficial for those at risk of
contracting HIV who have disengaged from medical institutions and primary care due to chronic
medical mistrust and the tiresome nature of having to constantly navigate institutional racism and
homophobia.
Implications for public health policy
It is not enough to simply make PrEP available to Medicare and Medicaid receipts, as it
has been in the state of Connecticut. It is vital that programs be created to provide PrEP, and all
necessary appointments and HIV tests to maintain a PrEP prescription to all. Providing these
services free of charge to all, regardless of citizenship status in the United States, as other
countries have done, would increase institutional trust and allow some who are currently unable
to engage with the healthcare system as they should be to do so.
Limitations
Important limitations of this study must be acknowledged. First, the number of
participants interviewed for this study represent a small sample of New Haven, Connecticut.
Additionally, PrEP was not intentionally a main focus of the interviews conducted. The fact that
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not every participant was asked or spoke about PrEP in their interviews may have impacted what
opinions of PrEP were sampled. Questions related to PrEP may have been primarily asked to
participants that the interviewers perceived to be at higher risk for HIV or with who HIV came
up easily in the course of the interview, which may have impacted the findings in this paper.
Additionally, as this is a qualitative study, these findings cannot be extrapolated to represent the
beliefs and perceptions of the entire communities sampled.
Conclusions
Understanding PrEP perceptions, stigma surrounding HIV and PrEP, and the origins and
manifestations of medical mistrust in various forms is crucial to understanding why some are
willing to try (and trust) PrEP and others are not. Historically, institutions have perpetrated largescale injustices against people of color under the guise of advancing research. It is no surprise
that institutional-based medical mistrust continues to be a massive barrier to engaging people of
color in healthcare, particularly preventative health care that involves pharmaceuticals. Increased
institutional accountability is paramount. PrEP is a valuable tool that can be leveraged as the
United States works toward its goal of eliminating HIV.
However, it is not enough to simply offer PrEP for HIV prevention. It is not even enough
to offer PrEP free of charge. Instead, it is vital that PrEP is offered in conjunction with adequate
sexual health education. PrEP must be clearly differentiated from disease-causing agents. All
primary care providers should be well educated about PrEP, and PrEP should be offered, without
judgement, to all patients. No one should get HIV because their provider was not knowledgeable
about HIV. Additionally, fear-based HIV prevention campaigns should be a thing of the past.
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Further research is needed to determine how primary care providers can work to overcome
generations of medical mistrust to better serve their African American and Hispanic patients.
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